Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,327.20
(
3.33%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
92.82
(
-8.29%
)
Bitcoin
71,760.14
(
-0.32%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: asmarterwookie post# 170544

Sunday, 03/30/2014 10:04:02 AM

Sunday, March 30, 2014 10:04:02 AM

Post# of 347009
Wook, I think that is the "easiest" entry into Big Pharma to allow Bavi combo's with everyone. That way... there is no preferential treatment or no monopoly of one Big Pharma dominating the market.

Soon, one day... I still say that $1 Trillion in Big Pharma spread over hundreds of companies will start to be pulled out "some" to diversify and again, 1% of $1 Trillion = $10 Billion

PPHM OS lets just up it to 200M.

$10B / 200M shares = $50 pps

thats just for starters I believe...and I know, its a very crude thought process

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote